Back to search

Article

Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: A case report and literature review

2022-02-07

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Rapidly progressive interstitial lung disease (RP-ILD) is a life-threatening complication of juvenile dermatomyositis (JDM); however, it is generally refractory to treatment and no evidence-based treatment has yet been established for RP-ILD. We present the case of a 2-year-old girl with RP-ILD who was resistant to methylprednisolone, cyclosporine A, cyclophosph...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5319c5d0-2ea5-5202-967d-4169b10e6e28
DOI
10.21203/rs.3.rs-1322720/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: A case report and literature reviewDOI 10.21203/rs.3.rs-1322720/v1
Adolescent-Onset Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Spontaneous Pneumomediastinum: A Case Report and Literature ReviewSemantic proximity
Rapidly progressive interstitial lung disease in the course of juvenile dermatomyositis: a case reportSemantic proximity
Treatment of Interstitial Lung Disease In Anti-MDA5-Positive Dermatomyositis: A Retrospective Study of 87 PatientsSemantic proximity
Anti-SAE Autoantibody-Positive Japanese Patient with Juvenile Dermatomyositis complicated with Interstitial Lung Disease - A Case ReportSemantic proximity
Case Report: Anti-MDA-5 dermatomyositis in a resource-limited settingSemantic proximity
Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.Semantic proximity
Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinibSemantic proximity
Comparison of Clinical Features and Prognostic Factors of Polymyositis/Dermatomyositis Associated Interstitial Lung Disease According to Autoantibodies: Anti-Aminoacyl tRNA Synthetase Antibodies Versus Anti-Melanoma Differentiation-Associated Gene 5 Antibody.Semantic proximity
Coexistence of anti-MDA5 and anti-PL-7 in a patient with dermatomyositis: a case reportSemantic proximity
Antibodies against Small Ubiquitin-Like Modifier Activating Enzyme Might Be A Protective Factor from Rapid Progressive Interstitial Lung Disease in Patients Bearing Antibodies against Melanoma Differentiation Associated Gene 5Semantic proximity
Correlation between lung microecology and immunity in patients with anti-MDA5 antibody-positive dermatomyositis combined with interstitial lung disease: protocol for a prospective, multicentre cohort studySemantic proximity
Select a neighboring publication to make it the new centre.